Anaes SAQs · Anaphylaxis under anaesthesia
NAP6 — the epidemiology of perioperative anaphylaxis
The NAP6 SAQ — the incidence (~1 in 10,000), the NMB agents as the leading culprit, the antibiotics second (teicoplanin), the 3-4% case fatality, and the management lesson (adrenaline under-dosed and delayed).
On this page
Study tools
Target exams
ANZCAFRCAABAEDAIC
Prompt
Outline the key findings of the 6th National Audit Project (NAP6) on perioperative anaphylaxis. Include the incidence, the commonest culprits, the mortality, and the management lessons.
Question
Outline the key findings of the 6th National Audit Project (NAP6) on perioperative anaphylaxis. Include the incidence, the commonest culprits, the mortality, and the management lessons.[1]
[1]References3ShowHide
- [1]Harper NJN, Cook TM, Garcez T, et al. Anaesthesia, surgery, and life-threatening allergic reactions: management and outcomes in the 6th National Audit Project (NAP6). British Journal of Anaesthesia, 2018.PMID 29935569
- [2]Harper NJN, Cook TM, Garcez T, et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). British Journal of Anaesthesia, 2018.PMID 29935567
- [3]Marinho S, Kemp H, Cook TM, et al. Cross-sectional study of perioperative drug and allergen exposure in UK practice in 2016: the 6th National Audit Project (NAP6) Allergen Survey. British Journal of Anaesthesia, 2018.PMID 29935566